Literature DB >> 31792335

Murine model of left ventricular diastolic dysfunction and electro-mechanical uncoupling following high-fat diet.

Serena L'Abbate1, Nicole Di Lascio1, Giuseppina Nicolini1, Francesca Forini1, Francesco Faita1, Claudia Kusmic2.   

Abstract

BACKGROUND/
OBJECTIVES: It is well established that obesity is an independent risk factor for cardiac death. In particular various cardiac alterations have been described in obese patients such as long QT on ECG, impaired diastolic filling of the left ventricle (LV), and all-type arrhythmias. In the present study, the above alterations were all reproduced in a mouse model of fat diet-induced obesity. ANIMALS/
METHODS: In C57BL6 mice fed on a high fat (n = 20, HF-group) or standard diet (n = 20, C-group) for 13 weeks, balanced by sex and age, we examined heart morphology and function by high-frequency ultrasounds and electric activity by surface ECG. Besides, the autonomic sympathovagal balance (heart-rate variability) and the arrhythmogenic susceptibility to adrenergic challenge (i.p. isoproterenol) were compared in the two groups, as well as glucose tolerance (i.p. glucose test) and liver steatosis (ultrasounds).
RESULTS: Body weight in HF-group exceeded C-group at the end of the experiment (+28% p < 0.01). An abnormal ventricular repolarization (long QTc on ECG) together with impaired LV filling rate and increased LV mass was found in HF-group as compared to C. Moreover, HF-group showed higher heart rate, unbalanced autonomic control with adrenergic prevalence and a greater susceptibility to develop rhythm disturbances under adrenergic challenge (i.p. isoprenaline). Impaired glucose tolerance and higher liver fat accumulation were also found in HF mice compared to C.
CONCLUSIONS: The described murine model of 13 weeks on HF diet, well reproduced the cardiovascular and metabolic disorders reported in clinical obesity, suggesting its potential utility as translational mean suitable for testing new pharmaco-therapeutic approaches to the treatment of obesity and its comorbidity.

Entities:  

Year:  2019        PMID: 31792335     DOI: 10.1038/s41366-019-0500-3

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  65 in total

1.  Modulators of normal electrocardiographic intervals identified in a large electronic medical record.

Authors:  Andrea H Ramirez; Jonathan S Schildcrout; Dana L Blakemore; Dan R Masys; Jill M Pulley; Melissa A Basford; Dan M Roden; Joshua C Denny
Journal:  Heart Rhythm       Date:  2010-10-29       Impact factor: 6.343

2.  The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study).

Authors:  Usha B Tedrow; David Conen; Paul M Ridker; Nancy R Cook; Bruce A Koplan; Joann E Manson; Julie E Buring; Christine M Albert
Journal:  J Am Coll Cardiol       Date:  2010-05-25       Impact factor: 24.094

3.  Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Rachel R Huxley; Faye L Lopez; Aaron R Folsom; Sunil K Agarwal; Laura R Loehr; Elsayed Z Soliman; Rich Maclehose; Suma Konety; Alvaro Alonso
Journal:  Circulation       Date:  2011-03-28       Impact factor: 29.690

Review 4.  Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications.

Authors:  Shilpa N Bhupathiraju; Frank B Hu
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

Review 5.  Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.

Authors:  José J Fuster; Noriyuki Ouchi; Noyan Gokce; Kenneth Walsh
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

Review 6.  Obesity and Cardiovascular Disease.

Authors:  Francisco B Ortega; Carl J Lavie; Steven N Blair
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

7.  Obesity-related cardiomyopathy is an adipocyte-mediated paracrine disease.

Authors:  Jane A Leopold
Journal:  Trends Cardiovasc Med       Date:  2014-10-02       Impact factor: 6.677

8.  Obesity and the risk of new-onset atrial fibrillation.

Authors:  Thomas J Wang; Helen Parise; Daniel Levy; Ralph B D'Agostino; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin
Journal:  JAMA       Date:  2004-11-24       Impact factor: 56.272

9.  Patients with metabolic syndrome have prolonged corrected QT interval (QTc).

Authors:  Weiju Li; Yongyi Bai; Kai Sun; Hao Xue; Yibo Wang; Xiaodong Song; Xiaohan Fan; Huijun Song; Yunfeng Han; Rutai Hui
Journal:  Clin Cardiol       Date:  2009-12       Impact factor: 2.882

10.  Health Effects of Overweight and Obesity in 195 Countries over 25 Years.

Authors:  Ashkan Afshin; Mohammad H Forouzanfar; Marissa B Reitsma; Patrick Sur; Kara Estep; Alex Lee; Laurie Marczak; Ali H Mokdad; Maziar Moradi-Lakeh; Mohsen Naghavi; Joseph S Salama; Theo Vos; Kalkidan H Abate; Cristiana Abbafati; Muktar B Ahmed; Ziyad Al-Aly; Ala’a Alkerwi; Rajaa Al-Raddadi; Azmeraw T Amare; Alemayehu Amberbir; Adeladza K Amegah; Erfan Amini; Stephen M Amrock; Ranjit M Anjana; Johan Ärnlöv; Hamid Asayesh; Amitava Banerjee; Aleksandra Barac; Estifanos Baye; Derrick A Bennett; Addisu S Beyene; Sibhatu Biadgilign; Stan Biryukov; Espen Bjertness; Dube J Boneya; Ismael Campos-Nonato; Juan J Carrero; Pedro Cecilio; Kelly Cercy; Liliana G Ciobanu; Leslie Cornaby; Solomon A Damtew; Lalit Dandona; Rakhi Dandona; Samath D Dharmaratne; Bruce B Duncan; Babak Eshrati; Alireza Esteghamati; Valery L Feigin; João C Fernandes; Thomas Fürst; Tsegaye T Gebrehiwot; Audra Gold; Philimon N Gona; Atsushi Goto; Tesfa D Habtewold; Kokeb T Hadush; Nima Hafezi-Nejad; Simon I Hay; Masako Horino; Farhad Islami; Ritul Kamal; Amir Kasaeian; Srinivasa V Katikireddi; Andre P Kengne; Chandrasekharan N Kesavachandran; Yousef S Khader; Young-Ho Khang; Jagdish Khubchandani; Daniel Kim; Yun J Kim; Yohannes Kinfu; Soewarta Kosen; Tiffany Ku; Barthelemy Kuate Defo; G Anil Kumar; Heidi J Larson; Mall Leinsalu; Xiaofeng Liang; Stephen S Lim; Patrick Liu; Alan D Lopez; Rafael Lozano; Azeem Majeed; Reza Malekzadeh; Deborah C Malta; Mohsen Mazidi; Colm McAlinden; Stephen T McGarvey; Desalegn T Mengistu; George A Mensah; Gert B M Mensink; Haftay B Mezgebe; Erkin M Mirrakhimov; Ulrich O Mueller; Jean J Noubiap; Carla M Obermeyer; Felix A Ogbo; Mayowa O Owolabi; George C Patton; Farshad Pourmalek; Mostafa Qorbani; Anwar Rafay; Rajesh K Rai; Chhabi L Ranabhat; Nikolas Reinig; Saeid Safiri; Joshua A Salomon; Juan R Sanabria; Itamar S Santos; Benn Sartorius; Monika Sawhney; Josef Schmidhuber; Aletta E Schutte; Maria I Schmidt; Sadaf G Sepanlou; Moretza Shamsizadeh; Sara Sheikhbahaei; Min-Jeong Shin; Rahman Shiri; Ivy Shiue; Hirbo S Roba; Diego A S Silva; Jonathan I Silverberg; Jasvinder A Singh; Saverio Stranges; Soumya Swaminathan; Rafael Tabarés-Seisdedos; Fentaw Tadese; Bemnet A Tedla; Balewgizie S Tegegne; Abdullah S Terkawi; J S Thakur; Marcello Tonelli; Roman Topor-Madry; Stefanos Tyrovolas; Kingsley N Ukwaja; Olalekan A Uthman; Masoud Vaezghasemi; Tommi Vasankari; Vasiliy V Vlassov; Stein E Vollset; Elisabete Weiderpass; Andrea Werdecker; Joshua Wesana; Ronny Westerman; Yuichiro Yano; Naohiro Yonemoto; Gerald Yonga; Zoubida Zaidi; Zerihun M Zenebe; Ben Zipkin; Christopher J L Murray
Journal:  N Engl J Med       Date:  2017-06-12       Impact factor: 91.245

View more
  1 in total

1.  Intracellular Redistribution of Left Ventricular Connexin 43 Contributes to the Remodeling of Electrical Properties of the Heart in Insulin-resistant Elderly Rats.

Authors:  Deniz Billur; Yusuf Olgar; Belma Turan
Journal:  J Histochem Cytochem       Date:  2022-05-24       Impact factor: 4.137

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.